$11.770
+0.031 (+0.26%)Zum Schluss
LFST-News
LFST-Events
Barclays Acts as Sole Book Running Manager for Offering
Barclays is acting as sole book running manager for the offering.
LifeStance Health Group to Offer 22.25M Shares of Common Stock
LifeStance Health Group announced that pursuant to a shelf registration statement filed with the SEC, certain stockholders of the company intend to offer 22.25M shares of LifeStance's common stock. The Selling Stockholders will receive all of the proceeds from the offering. The company is not selling any shares of Common Stock in the offering and will not receive any proceeds from the offering. Barclays is acting as the underwriter for the offering.
LifeStance Stock Rises 13.2% to $12.27
LifeStance is up 13.2%, or $1.43 to $12.27.
2026 Consensus Adjusted EBITDA Forecast $215M-$235M
2026 consensus $1.66B. Sees 2026 adjusted EBITDA $215M-$235M.
Sees Q3 Adjusted EBITDA of $49M-$59M
Sees Q3 adjusted EBITDA $49M-$59M.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.